Epigenetics as a paradigm for cancer treatment [electronic resource] : chemically targeting the histone lysine methyltransferase EZH2 / Sharad K. Verma.
Material type:![Film](/opac-tmpl/lib/famfamfam/VM.png)
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Cancer as an unmet medical need -- Epigenetics as a paradigm for treating cancer -- Histone lysine methyltransferase EZH2 as a target class example -- Development of EZH2 inhibitors.
Access restricted to subscribers.
Mode of access: World Wide Web.